Incidence

  • Rare
  • Arises from D2 pancreatic islet cells
  • Clinical Syndrome – WDHA
    • Watery
    • Diarrhoea
    • Hypokalaemia
    • Achlorhydria (absent HCl in gastric secretions)
  • 2/3 malignant
  • 70% have metastatic disease at presentation

  • 90% found in Pancreas
  • 10% in Colon, Bronchus, Liver, Adrenal, Sympathetic Ganglia
  • Most middle age
    • 10% diagnosed before 10yrs old (but generally VIPomas from neuroblastomas etc rather than PNETS)
  • Generally solitary, > 3cm, easily seen on CT/MRI
  • 75% in body and tail of pancreas
  • 95% Sporadic, 5% MEN1

Presentation and Diagnosis

  • Watery secretory diarrhoea
    • Can be 3-5L per day, Unlikely VIPoma if < 700mLs
    • Persists despite fasting, and despite NG aspiration (c.f. ZES)
  • Weight loss, crampy abdo pain, electrolyte abnormalities
  • Metabolic acidosis (fluid and bicarb loss)
    • Hypokalaemia can be profound
    • 75% have hypochlorhydria/achlorhydria
      • Absence HCL in gastric secretions (VIP inhibits gastric secretion)
  • Diagnosis - VIP levels 225-2000pg/mL
    • Measured after overnight fast
    • Normal levels < 200

Treatment

  • Initial
    • Aggressive rehydration and correction of electrolytes and acid-base disturbance
    • Octreotide to decrease diarrhoea volumes
    • If diarrhoea persists, steroid can help
  • Surgery
    • Anatomic resection with lymphadenectomy rather than enucleation
    • No evidence to support debulking in metastatic disease
  • After resection
    • 5yr survival 68%
    • Metastases = Poor prognostic factor